All News #Library
Biotech
Enthorin Starts Phase 2 Trial Of MRM-3379 For Fragile X Syndrome
09 Jan 2026 //
BUSINESSWIRE
US FDA approves Mirum Pharma`s genetic disorder drug
22 Feb 2025 //
REUTERS

Market Place
Sourcing Support